{"url_path":"/sec/rpid/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001380106-26-000067-index.html","accession_number":"0001380106-26-000067","cik":"0001380106","ticker":"RPID","issuer_name":"RAPID MICRO BIOSYSTEMS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1380106/0001380106-26-000067-index.html","primary_entity_key":"0001380106","primary_entity_name":"RAPID MICRO BIOSYSTEMS, INC."},"word_count":90,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d)Exhibits.\n\nExhibit No.Description\n\n[99.1](rpid-20260331xexx991.htm)\n\n[Press Release of Rapid Micro Biosystems, Inc., dated May 1](rpid-20260331xexx991.htm)[3](rpid-20260331xexx991.htm)[, 2026, related to its financial results for its first quarter ended March 31, 2026.](rpid-20260331xexx991.htm)\n\n[104](#i60ae0cd74b4446bca5f9038f4e8bc4f6_1)\n\n[Cover Page Interactive Data File (formatted as inline XBRL)](#i60ae0cd74b4446bca5f9038f4e8bc4f6_1)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nRAPID MICRO BIOSYSTEMS, INC.\n\nDate: May 13, 2026By:/s/ Sean Wirtjes\n\nSean Wirtjes\n\nChief Financial Officer"}